• Title/Summary/Keyword: OEAV

Search Result 2, Processing Time 0.014 seconds

Optimized Entity Attribute Value Model: A Search Efficient Re-presentation of High Dimensional and Sparse Data

  • Paul, Razan;Latiful Hoque, Abu Sayed Md.
    • Interdisciplinary Bio Central
    • /
    • v.3 no.3
    • /
    • pp.9.1-9.5
    • /
    • 2011
  • Entity Attribute Value (EAV) is the widely used solution to represent high dimensional and sparse data, but EAV is not search efficient for knowledge extraction. In this paper, we have proposed a search efficient data model: Optimized Entity Attribute Value (OEAV) for physical representation of high dimensional and sparse data as an alternative of widely used EAV. We have implemented both EAV and OEAV models in a data warehousing en-vironment and performed different relational and warehouse queries on both the models. The experimental results show that OEAV is dramatically search efficient and occupy less storage space compared to EAV.

The role of Fatty acid binding protein 5 (Fabp5) in fatty acid partitioning in the liver (간에서 지방산 분할에 대한 지방산결합 단백질 5의 역할)

  • Park, Jae-Seung
    • Journal of Digital Convergence
    • /
    • v.17 no.8
    • /
    • pp.283-291
    • /
    • 2019
  • The aim of investigated the role of FABP5 in the hepatic lipogenesis and lipid metabolisms. Mice were overexpressed and silenced liver FABP5 using virus particles. Mice were fed a Western-type diet or regular chow for 1week and then sacrificed mouse after 24hr fasted. Liver homogenates were used for protein analysis by Western blot and mRNA levels by RT-PCR. Hepatic and serum lipids were analysed by thin-layer chromatography. Mice fed a Western-type or high saturated fat diet revealed large increases in FABP5 expression. However, FABP5 mRNA levels were drastically reduced under fasted. Hepatic TG was significantly increased FABP5-OEAV mice, but a significantly decreased hepatic free cholesterol under fed. The discovered a substantial decrease in hepatic TG mass with FABP5 silencing. In these data, presented evidence for an important role of FABP5 in hepatic lipogenesis and hepatic TG storage. FABP5 may also be a potential target in the treatment of NAFLD, metabolic syndrome, and obesity. Furthermore, studies to which transcription factors are involved in FABP5 expression and regulation.